BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1755705)

  • 1. [Obtaining human recombinant (serine-17) beta-interferon by the method of oligonucleotide-directed mutagenesis and its expression in Escherichia coli].
    Shekhter II; Beĭko VP; Bulenkov MT; Khodova OM; Kolevatykh MA; Izotova LS; Lebedeva MI; Rudenskiĭ AIu; Borukhov SI; Iurin VI
    Antibiot Khimioter; 1991 Aug; 36(8):25-8. PubMed ID: 1755705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of 125I-labeled recombinant beta interferon (IFN-beta Ser17) to human cells.
    O'Rourke EC; Drummond RJ; Creasey AA
    Mol Cell Biol; 1984 Dec; 4(12):2745-9. PubMed ID: 6441889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of Zwittergent 3-14 in the purification of recombinant human interferon-beta Ser17 (Betaseron).
    Russell-Harde D; Knauf M; Croze E
    J Interferon Cytokine Res; 1995 Jan; 15(1):31-7. PubMed ID: 7648432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isolation of expressed in E. coli human interferon beta1b (Ser17) by ion-exchange chromatography].
    Romanov VP; Bezuglov VV; Bobrov MIu; Kostromina TI; Feofanov SA; Miroshnikov AI
    Bioorg Khim; 2011; 37(3):327-33. PubMed ID: 21899047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term stability of recombinant (serine-17) human interferon-beta.
    Geigert J; Panschar BM; Fong S; Huston HN; Wong DE; Wong DY; Taforo C; Pemberton M
    J Interferon Res; 1988 Aug; 8(4):539-47. PubMed ID: 3171246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potency stability of recombinant (Serine-17) human interferon-beta.
    Geigert J; Ziegler DL; Panschar BM; Creasey AA; Vitt CR
    J Interferon Res; 1987 Apr; 7(2):203-11. PubMed ID: 3039014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optimization of cultivation conditions for strains of Escherichia coli--a producer of recombinant alpha-2b-interferon].
    Orlovs'ka IV; Hrabchenko NI; Spivak MIa
    Mikrobiol Z; 2007; 69(2):50-5. PubMed ID: 17494335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intact protein analysis for site-directed mutagenesis overexpression products: plasmid-encoded R67 dihydrofolate reductase.
    VerBerkmoes NC; Strader MB; Smiley RD; Howell EE; Hurst GB; Hettich RL; Stephenson JL
    Anal Biochem; 2002 Jun; 305(1):68-81. PubMed ID: 12018947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered disulfide bond greatly increases specific activity of recombinant murine interferon-beta.
    Day C; Schwartz B; Li BL; Pestka S
    J Interferon Res; 1992 Apr; 12(2):139-43. PubMed ID: 1578187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Betaseron.
    Lin L
    Dev Biol Stand; 1998; 96():97-104. PubMed ID: 9890522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of antibodies to interferon-beta in patients treated with recombinant human interferon-beta 1a from mammalian cells.
    Abdul-Ahad AK; Galazka AR; Revel M; Biffoni M; Borden EC
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):27-32. PubMed ID: 9287241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Site-directed mutagenesis with the use of addressed fragmentation of single-stranded DNA for obtaining hybrids of homologous proteins].
    Shekhter II; Ratmanova KI; Veĭko VP; Debabov VG
    Bioorg Khim; 1991 Mar; 17(3):379-86. PubMed ID: 1648356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hybrid human lymphokine genes. I. Design of recombinant plasmids coding hybrids of immune interferon and human tumor necrosis factor].
    Korobko VG; Davydov IV; Shingarova LN; Filippov SA; Esipov DS; Berkova NP; Dobrynin VN
    Bioorg Khim; 1991 Feb; 17(2):189-96. PubMed ID: 1907451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering HlyA hypersecretion in Escherichia coli based on proteomic and microarray analyses.
    Lee PS; Lee KH
    Biotechnol Bioeng; 2005 Jan; 89(2):195-205. PubMed ID: 15580578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Optimization of cultivation conditions of recombinant Escherichia coli strain KPR-42--producer of human gamma-interferon].
    Koboziev IuO; Sorochyns'ka UB; Mel'nyk AI; Pylypenko VH; Spivak MIa
    Mikrobiol Z; 2006; 68(1):41-7. PubMed ID: 16686217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning, high expression and purification of recombinant human intereferon-beta-1b in Escherichia coli.
    Rao DV; Ramu CT; Rao JV; Narasu ML; Rao AK
    Appl Biochem Biotechnol; 2009 Jul; 158(1):140-54. PubMed ID: 18679594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and purification of Escherichia coli beta-glucuronidase.
    Aich S; Delbaere LT; Chen R
    Protein Expr Purif; 2001 Jun; 22(1):75-81. PubMed ID: 11388802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High productivity of human recombinant beta-interferon from a low-temperature perfusion culture.
    Rodriguez J; Spearman M; Tharmalingam T; Sunley K; Lodewyks C; Huzel N; Butler M
    J Biotechnol; 2010 Dec; 150(4):509-18. PubMed ID: 20933553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico analysis of different signal peptides to discover a panel of appropriate signal peptides for secretory production of Interferon-beta 1b in Escherichia coli.
    Ghovvati S; Pezeshkian Z; Mirhoseini SZ
    Acta Biochim Pol; 2018 Oct; 65(4):521-534. PubMed ID: 30378597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
    Yan X; Hu S; Guan YX; Yao SJ
    Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.